Meeting
2018 ASCO Annual Meeting
International harmonization of diagnostic criteria for HER2-amplified metastatic colorectal cancer and application of targeted next-generation sequencing panel as a diagnostic method.
Authors
Satoshi Fujii
National Cancer Center, EPOC, Chiba, Japan
Satoshi Fujii , Anthony Martin Magliocco , Emanuele Valtorta , Jihun Kim , Wataru Okamoto , Jeong Eun Kim , Kentaro Sawada , Yoshiaki Nakamura , Valter Torri , Scott Kopetz , Woong Yang Park , Katsuya Tsuchihara , Tae Won Kim , Kanwal Pratap Singh Raghav , Salvatore Siena , Takayuki Yoshino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3594)
DOI
10.1200/JCO.2018.36.15_suppl.3594
Abstract #
3594
Poster Bd #
87
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers.
First Author: Joshua Z. Drago
Poster
2020 ASCO Virtual Scientific Program
Comprehensive analysis of HER2 status through genomic, transcription, and translation among 5,305 patients with diverse malignancies.
First Author: Akram Mesleh Shayeb
Poster
2015 Gastrointestinal Cancers Symposium
Therapeutic dual inhibition of HER2 pathway for metastatic colorectal cancer (mCRC): The HERACLES trial.
First Author: Salvatore Siena
Poster
2023 ASCO Gastrointestinal Cancers Symposium
HER2 testing in colorectal cancer: Concordance analysis between breast and gastric scoring algorithms from the MOUNTAINEER trial.
First Author: Andrea Cercek